Suchergebnisse - "Podzamczer, Daniel"

PubPharm (305)

91

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial

enthalten in: PloS one | 2016

von Cooper, D. | Cordery, D. | Zajdenverg, R. | +87

92

Cerebrospinal fluid and plasma lopinavir concentrations and viral response in virologically suppressed patients switching to lopinavir/ritonavir monotherapy once daily

enthalten in: Antiviral therapy | 2016

von Tiraboschi, J. | Knobel, H. | Imaz, A. | +9

93

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients : 48 Week Results of the SIMRIKI Retrospective Study

enthalten in: PloS one | 2016

von Troya, J. | Ryan, P. | Ribera, E. | +19

ErratumIn: PLoS One. 2017 Feb 9;12 (2):e0172184. - PMID 28182783

94

HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen

Erschienen: 2016

von Imaz, A. | Martinez-Picado, J. | Niubó, J. | +9

95

Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular risk

enthalten in: Atherosclerosis | 2016

von Saumoy, M. | Alonso-Villaverde, C. | Navarro, A. | +9

96

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection

enthalten in: Clinical infectious diseases | 2016

von Nicolás, D. | Esteve, A. | Cuadros, A. | +22

97

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection

enthalten in: Clinical infectious diseases | 2016

von Nicolás, D. | Esteve, A. | Cuadros, A. | +22

98

MARAVIROC ONCE-DAILY: EXPERIENCE IN ROUTINE CLINICAL PRACTICE

enthalten in: Aids research and human retroviruses | 2016

von Saumoy, M. | Llibre, J. | Terrón, A. | +7

99

HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen

enthalten in: The journal of infectious diseases | 2016

von Imaz, A. | Martinez-Picado, J. | Niubó, J. | +9

100

Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients

enthalten in: The journal of antimicrobial chemotherapy | 2016

von Curran, A. | Rojas, J. | Cabello, A. | +10